"Reduced Bleeding Risk: Stopping Aspirin 1 Month After Stent"
New research suggests that heart patients who undergo percutaneous coronary interventions may be able to stop taking aspirin after just one month, while continuing a second blood thinner for 12 months, without experiencing an increased risk of blood clots forming on the implanted hardware. The study found a 55% reduction in bleeding issues with no additional occurrence of cardiac events when patients stopped taking aspirin after one month. This finding may lead to a change in guidelines for post-procedure antiplatelet medications, offering a potentially safer strategy for patients undergoing these heart procedures.
